Immatics (IMTX) Dividends Paid - Common (2019 - 2025)
Immatics (IMTX) posted Dividends Paid - Common of $12.8 million for Q4 2025, down 86.01% sequentially from $91.5 million in Q3 2025, and down 74.81% YoY from $50.8 million in Q4 2024.
Immatics (IMTX) Dividends Paid - Common (2019 - 2025) Analysis & Trends
Immatics has reported Dividends Paid - Common for 6 years, with the latest figure at $12.8 million in Q4 2025.
- Quarterly Dividends Paid - Common fell 74.81% year-over-year to $12.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $375.4 million (up 46.42% YoY) and the FY2025 annual result came in at $390.8 million, up 52.52% from the prior year.
- Dividends Paid - Common slipped to $12.8 million in Q4 2025 per IMTX's latest filing, from $91.5 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $277.6 million in Q1 2022 and troughed at -$87.8 million in Q3 2022.
- A 4-year average of $66.9 million and a median of $34.1 million in 2024 frame the typical range for Dividends Paid - Common.
- The sharpest annual moves came in 2021 and 2022: Dividends Paid - Common soared 195.61% in 2021, then slumped 6299.04% in 2022.
- Over 4 years, Dividends Paid - Common stood at -$32.4 million in 2021, then sank by 171.2% to -$87.8 million in 2022, then jumped by 157.87% to $50.8 million in 2024, then slumped by 74.81% to $12.8 million in 2025.
- According to Business Quant data, Dividends Paid - Common over the past three periods registered $12.8 million, $91.5 million, and $15.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 12.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Sep 30, 2025 | 91.52 Mn |
| Sep 30, 2025 | 91.52 Mn |
| Jun 30, 2025 | 15.61 Mn |
| Jun 30, 2025 | 15.61 Mn |
| Mar 31, 2025 | 255.44 Mn |
| Mar 31, 2025 | 255.44 Mn |
| Dec 31, 2024 | 50.81 Mn |
| Dec 31, 2024 | 50.81 Mn |
| Sep 30, 2024 | 34.11 Mn |
| Sep 30, 2024 | 34.11 Mn |
| Jun 30, 2024 | 38.82 Mn |
| Jun 30, 2024 | 38.82 Mn |
| Mar 31, 2024 | 132.64 Mn |
| Mar 31, 2024 | 132.64 Mn |
| Sep 30, 2022 | -87.80 Mn |
| Sep 30, 2022 | -87.80 Mn |
| Jun 30, 2022 | 19.00 Mn |
| Jun 30, 2022 | 19.00 Mn |